Naba Alsaha Medical Services Company
TADAWUL:9546.SR
91 (SAR) • At close September 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Revenue
| 182.352 | 129.684 | 117.682 | 115.683 |
| Cost of Revenue
| 108.583 | 78.045 | 70.898 | 69.751 |
| Gross Profit
| 73.769 | 51.639 | 46.783 | 45.932 |
| Gross Profit Ratio
| 0.405 | 0.398 | 0.398 | 0.397 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 6.055 | 4.384 | 4.758 | 17.226 |
| Selling & Marketing Expenses
| 24.133 | 0.499 | 1.253 | 1.058 |
| SG&A
| 30.188 | 4.384 | 4.758 | 18.284 |
| Other Expenses
| 3.578 | 1.097 | 0 | 0 |
| Operating Expenses
| 30.188 | 22.231 | 18.889 | 18.284 |
| Operating Income
| 43.581 | 28.311 | 26.972 | 27.648 |
| Operating Income Ratio
| 0.239 | 0.218 | 0.229 | 0.239 |
| Total Other Income Expenses Net
| 11.997 | 0.623 | 0.556 | 0.688 |
| Income Before Tax
| 55.578 | 28.934 | 27.528 | 28.336 |
| Income Before Tax Ratio
| 0.305 | 0.223 | 0.234 | 0.245 |
| Income Tax Expense
| 2.48 | 2.012 | 1.701 | 1.683 |
| Net Income
| 52.382 | 26.923 | 25.827 | 26.653 |
| Net Income Ratio
| 0.287 | 0.208 | 0.219 | 0.23 |
| EPS
| 4.99 | 2.56 | 2.46 | 2.54 |
| EPS Diluted
| 4.99 | 2.56 | 2.46 | 2.54 |
| EBITDA
| 53.076 | 35.91 | 33.899 | 33.738 |
| EBITDA Ratio
| 0.291 | 0.277 | 0.288 | 0.292 |